Medical Imaging And Therapeutics LLC Leesburg, FL - 34748

Medical Imaging And Therapeutics LLC is categorized under Health Services in Leesburg, FL and active since 2012.

Medical Imaging And Therapeutics LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.

If you are seeking more information, feel free to contact Mark D Jacobson at the company’s single location by writing to 922 Shore Acres Drive, Leesburg, Florida FL 34748 or by phoning (352) 430-7788. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medical Imaging And Therapeutics LLC
Contact Person: Mark D Jacobson
Address: 922 Shore Acres Drive, Leesburg, Florida 34748
Phone Number: (352) 430-7788
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:

Medical Imaging And Therapeutics LLC was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Mark D Jacobson for inquiries that concern Medical Imaging And Therapeutics LLC by calling the company number (352) 430-7788, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Imaging And Therapeutics LLC can be found at the coordinates 28.820944,-81.864713 as well as the street address 922 Shore Acres Drive in Leesburg, Florida 34748.

For its online presence, you may visit Medical Imaging And Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.